.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Agilus Diagnostics has launched the automated Idylla system at its Goregaon laboratory in Mumbai. This advanced platform revolutionizes clinical workflows by delivering rapid cancer mutation testing in just 2.5 to 3 hours. Consequently, clinicians can now bypass conventional testing methods that typically take several days to process.
Furthermore, this technology allows oncologists to make timely, biomarker-driven treatment decisions during critical windows. Because of this speed, patients can begin targeted therapies without unnecessary delays.
The cartridge-based Idylla platform fully automates the testing process. Specifically, it integrates sample processing, nucleic acid extraction, amplification, and detection into a single workflow. Therefore, it minimizes manual intervention and reduces pre-analytical variability. This automation ensures highly accurate and reproducible results.
Additionally, the system detects critical genetic mutations across various cancer types. For instance, it identifies EGFR mutations, which frequently occur in lung cancer patients within Indian and Asian populations. It also screens for KRAS and NRAS mutations, which are crucial biomarkers in colorectal and pancreatic cancers. Moreover, it detects BRAF mutations found in melanoma and colorectal cancers.
Beyond these standard markers, the platform supports testing for emerging biomarkers. These include Microsatellite Instability (MSI) and IDH1/IDH2 mutations. Consequently, clinicians can better determine patient eligibility for advanced immunotherapies and targeted treatments.
Oncologists often face limited tissue samples in advanced cases. Therefore, the ability to obtain reliable genomic insights quickly is invaluable. The platform's high analytical performance helps optimize clinical outcomes when time is of the essence. As a result, India is taking a major step forward in expanding access to precision medicine.
Q1: What is the main advantage of the Idylla molecular diagnostics system?
The system delivers highly accurate genetic mutation results within 2.5 to 3 hours. Consequently, it is significantly faster than traditional molecular tests that require several days.
Q2: Which cancer biomarkers can this platform detect?
The platform identifies key mutations such as EGFR, KRAS, NRAS, and BRAF. Additionally, it supports testing for emerging markers like MSI and IDH1/IDH2.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Agilus Diagnostics has launched the cartridge-based Idylla molecular diagnostics system in Mumbai. The automated platform reduces cancer mutation testing times to 2.5–3 hours, enabling clinicians to identify key genetic biomarkers and initiate targeted therapies much faster than conventional methods.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
